Filter Transactions
View:
Tiles
List
Type:
Sector:
Sort by:
Envista Holdings
Value: $517.5 Million
Date: 05/18/2020

Independent capital markets advisor to Envista on $450M private placement of convertible notes

Closed
Cantel Medical Corp
Value: $168 Million
Date: 05/13/2020

Independent Capital Markets Advisor to Cantel on $140M convertible notes offering

Closed
Royal Caribbean Cruises
Value: $3.32 Billion
Date: 05/13/2020

Financial advisor to Royal Caribbean in connection with its $3.32B senior secured notes offering

Pending
Del Monte Foods, Inc
Value: $975 Million
Date: 05/04/2020

Exclusive financial advisor to Del Monte Foods, Inc. and Del Monte Pacific Limited on capital structure refinancing

Pending
Quintana Energy Services Inc
Value: $36 Million
Date: 05/03/2020

Exclusive financial advisor to Quintana Energy Services in its all-stock merger with KLX

Pending
Baker Hughes
Value: Undisclosed
Date: 05/01/2020

TPH served as financial advisor to Baker Hughes Company on the sale of its Lufkin Rod Lift Solutions Business

Pending
Sabre Corporation
Value: $1.1 Billion
Date: 04/13/2020

Financial advisor and co-manager to Sabre on its $1.1 billion secured and exchangeable note offerings

Closed
Nevro Corp
Value: $346.7 Million
Date: 04/01/2020

Independent Capital Markets Advisor to Nevro on $301.5M convertible notes and common stock offering

Closed
Royal Caribbean Cruises
Value: $2.35 Billion
Date: 03/23/2020

Financial advisor to Royal Caribbean in connection with its $2.35B secured term loan

Pending
NuVasive
Value: $450 Million
Date: 02/26/2020

Independent Capital Markets advisor to NuVasive on $450M private placement of convertible notes

Closed
Waters Corporation
Value: Undisclosed
Date: 01/13/2020

Exclusive financial advisor to Waters on the acquisition of Andrew Alliance S.A.

Closed
Esteve
Value: Undisclosed
Date: 01/08/2020

Exclusive financial advisor to Esteve on its acquisition of Riemser Pharma

Pending
Morgan Stanley Infrastructure Partners / Horizon Equity Partners
Value: Undisclosed
Date: 01/02/2020

Exclusive financial advisor to Morgan Stanley Infrastructure Partners and Horizon Equity Partners in connection with the sale of their 75% stake in OMTEL

Closed
Ultragenyx Pharmaceutical Inc
Value: $320 Million
Date: 12/18/2019

Financial advisor to Ultragenyx on the sale of future royalties to Royalty Pharma

Closed
Groupe PSA
Value: €43 Billion
Date: 12/18/2019

Sole Financial Advisor to the Supervisory Board of Groupe PSA on its merger with Fiat Chrysler Automobiles

Pending